Charles Douglas Stutesman

PA-C | Psychiatry | Addiction Medicine


  119 Tunnel Rd Ste D, Asheville
     North Carolina, 28805-1800
  919-449-5887    Maps & Directions
Charles Douglas Stutesman is a Asheville, North Carolina based psychiatrist who is specialized in Addiction Medicine. His current practice location is 119 Tunnel Rd Ste D, Asheville. Patients can reach him at 919-449-5887. Charles Douglas Stutesman is PA-C in Addiction Medicine and his NPI number (Unique professional ID assigned by NPPES) is 1417548660.
Charles Douglas Stutesman focuses on the evaluation, diagnosis, and treatment of people who have one or more disorders related to addictions like illegal drugs, alcohol, and prescription medication and other substances.
Complete Profile:
Charles Douglas Stutesman speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for appointment.
Name: Charles Douglas Stutesman
Specialization: Addiction Medicine
Gender:Male
Credentials: PA-C
Practice Address:119 Tunnel Rd Ste D, Asheville,
North Carolina, 28805-1800
Phone:919-449-5887
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
NPI Number: 1417548660
NPI Enumeration Date: 31 Jan, 2021
NPI Last Update On: 06 Feb, 2023

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: Charles Douglas Stutesman
10 Terrapin Trl,
Flat Rock, North Carolina
Zip: 28731-9633
Phone Number: 919-449-5887
Patients can reach Charles Douglas Stutesman at 119 Tunnel Rd Ste D, Asheville, North Carolina or can call to book an appointment on 919-449-5887.
Comments/ Reviews:

Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.